ArticleThe World Allergy Organization journal2025

Global prevalence of eligibility for biologic therapy in ATS/ERS-defined severe asthma: A systematic review.

Freda Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.